|
09 Dec 2019 |
Autolus Therapeutics Announces New Data Showcasing Clinical Progress of AUTO3 in B Cell Malignancies
|
|
09 Dec 2019 |
Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
|
|
09 Dec 2019 |
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
|
|
09 Dec 2019 |
61st ASH Congress 2019: Menarini Ricerche presents the latest updates about the First In Human clinical trial of SEL24/MEN1703
|
|
09 Dec 2019 |
First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma
|
|
09 Dec 2019 |
Viracta Announces Positive Phase 1b/2 Data Presented at Oral Presentation on Lead Program for Epstein-Barr Virus (EBV)-associated Relapsed/Refractory Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
|
|
09 Dec 2019 |
Nouscom - First Patient Dosed in a Phase 1 Trial With NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine, in MSI-High Solid Tumors
|
|
09 Dec 2019 |
Moberg Pharma Meets Primary Endpoint for MOB-015 in a Phase 3 Study for the Treatment of Onychomycosis
|
|
09 Dec 2019 |
Cerevel Therapeutics Announces Phase 1 Results for CVL-865, a Novel α2/3/5-subtype GABAA Positive Allosteric Modulator in Development to Treat Epilepsy
|
|
09 Dec 2019 |
Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors
|
|
09 Dec 2019 |
Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis
|
|
09 Dec 2019 |
Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases
|
|
09 Dec 2019 |
Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting
|
|
09 Dec 2019 |
Ziopharm Oncology Presents Pre-Clinical Data Validating “Rapid Personalized Manufacture” (RPM) with TCR at the 2019 American Society for Hematology Annual Meeting
|
|
09 Dec 2019 |
Immunocore announces dosing of first patient with third ImmTAC® bispecific
|
|
08 Dec 2019 |
Molecular Partners Presents Updated Results of MP0250 in Patients with Relapsed/Refractory Multiple Myeloma (MM) at American Society of Hematology
|
|
08 Dec 2019 |
Kymab Presents Updates at the American Society of Hematology (ASH) 61st Annual Meeting and Exposition
|
|
08 Dec 2019 |
Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting
|
|
08 Dec 2019 |
Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers
|
|
08 Dec 2019 |
Unum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual Meeting
|
